高级检索
当前位置: 首页 > 详情页

Downregulation of HULC Induces Ferroptosis in Hepatocellular Carcinoma via Targeting of the miR-3200-5p/ATF4 Axis

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

单位: [1]Medical Research Center, Henan International Joint Laboratory of Thrombosis and Hemostasis, School of Basic Medicine, Henan University of Science and Technology, Luoyang 471000, China. [2]Department of Geriatric Medicine, Jiaozuo People's Hospital, Xinxiang Medical University, Jiaozuo 454000, China. [3]Department of Immunology, Key Laboratory of Immune Microenvironment and Disease of the Educational Ministry of China, Tianjin Key Laboratory of Cellular and Molecular Immunology, School of Basic Medical Sciences, Tianjin Medical University, 300070 Tianjin, China. [4]Liver Transplantation Center, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China. [5]Department of General Surgery, Jiaozuo People's Hospital, Xinxiang Medical University, Jiaozuo 454000, China.
出处:
ISSN:

摘要:
Hepatocellular carcinoma is a malignant tumor that poses a serious threat to human health. Ferroptosis, which represents an identified type of regulated iron-dependent cell death, may play an important role in hepatocellular carcinoma. However, it is unclear as to whether ferroptosis is involved with the mechanisms of lncRNA HULC in liver cancer cells. Here, we show that knockdown of HULC increases ferroptosis and oxidative stress in liver cancer cells. We also found changes in some related miRNAs in cells treated with HULC siRNA. Differential miRNA expression levels were determined with the use of high-throughput sequencing and prediction target genes identified using bioinformatics analysis. HULC was found to function as a ceRNA of miR-3200-5p, and miR-3200-5p regulates ferroptosis by targeting ATF4, resulting in the inhibition of proliferation and metastasis within HCC cells. In summary, these findings illuminate some of the molecular mechanisms through which downregulation of HULC induces liver cancer cell ferroptosis by targeting the miR-3200-5p/ATF4 axis to modulate the development of hepatocellular carcinoma.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2021]版:
大类 | 2 区 生物学
小类 | 3 区 细胞生物学
最新[2025]版:
JCR分区:
出版当年[2020]版:
Q2 CELL BIOLOGY
最新[2023]版:

影响因子: 最新[2023版] 最新五年平均[2021-2025] 出版当年[2020版] 出版当年五年平均[2016-2020] 出版前一年[2019版] 出版后一年[2021版]

第一作者:
第一作者单位: [1]Medical Research Center, Henan International Joint Laboratory of Thrombosis and Hemostasis, School of Basic Medicine, Henan University of Science and Technology, Luoyang 471000, China.
共同第一作者:
通讯作者:
通讯机构: [4]Liver Transplantation Center, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China. [5]Department of General Surgery, Jiaozuo People's Hospital, Xinxiang Medical University, Jiaozuo 454000, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:1320 今日访问量:0 总访问量:816 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)